Compare CVS Health Corp (CVS) vs Robinhood Markets, Inc. (HOOD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Robinhood Markets, Inc. — how do they compare? CVS Health Corp trades at $86.2 (market cap $112.49B), while Robinhood Markets, Inc. trades at $108.86 (market cap $98.46B). The key difference: CVS Health Corp and Robinhood Markets, Inc. are close in size by market cap, and CVS Health Corp pays a 3.02% dividend while Robinhood Markets, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Robinhood Markets, Inc. for 75 Days on average.
| CVS | HOOD | |
|---|---|---|
Market Cap | $112.49B | $98.46B |
Volume | 8,467,392 | 18,771,023 |
Sector | Health | Financials |
52-Week High | $110.60 | $152.46 |
52-Week Low | $70.08 | $65.16 |
Typical Hold Time | 83 Days | 75 Days |
Enterprise Value | $174.83B | $105.00B |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Robinhood (HOOD) trades at $107.01, down 4.46% today, with a bullish technical signal and strong support at $105. The company reported robust revenue growth to $4.47B in 2025, with a net income margin of 42.01%, though valuation ratios like P/E of 48.46 are elevated. Recent news highlights expansion into 24/7 stock trading and AI-driven features, signaling innovation.
Outlook is positive with a consensus price target of $137, implying 28% upside, driven by product launches and market share gains. Risks include high valuation sensitivity and regulatory scrutiny over new offerings. Analyst sentiment is strongly bullish (77% buy ratings), but investors should monitor execution amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →
